Invention Grant
- Patent Title: Covalent inhibitors of CDK-7
-
Application No.: US15706980Application Date: 2017-09-18
-
Publication No.: US10195200B2Publication Date: 2019-02-05
- Inventor: Yi Chen , Yan Lou
- Applicant: Newave Pharmaceutical Inc.
- Applicant Address: US CA Pleasanton
- Assignee: Newave Pharmaceutical Inc.
- Current Assignee: Newave Pharmaceutical Inc.
- Current Assignee Address: US CA Pleasanton
- Agency: McCarter & English, LLP
- Agent Yu Lu; Wei Song
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/165 ; A61K31/397 ; A61K31/4015 ; A61K31/45 ; A61K31/497 ; C07D498/08 ; C07D491/06 ; C07D325/00
Abstract:
The disclosure includes compounds of Formula (I) wherein R0, R1, R2, R3, R4, R5, and L are defined herein. Also disclosed is a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds.
Public/Granted literature
- US20180008604A1 COVALENT INHIBITORS OF CDK-7 Public/Granted day:2018-01-11
Information query
IPC分类:
